MarginsXMarginsX
Home › Markets › Health Care › CDIO

Cardio Diagnostics Holdings Inc. (CDIO)

CDIO trades on Nasdaq in Health Care, Biotechnology: In Vitro & In Vivo Diagnostic Substances. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.79
-7.26% on the day
Market cap
$5.3M
Nano cap
Revenue · 2025
$15K
-57.5% on 2024
Net income · 2025
-$6.5M
-43832.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1870144/000155335026000023/0001553350-26-000023-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCDIO on Nasdaq
SectorHealth Care
IndustryBiotechnology: In Vitro & In Vivo Diagnostic Substances
CountryUnited States
IPO year2022
SEC CIK0001870144
SEC industry codeIn Vitro & In Vivo Diagnostic Substances
Incorporated inDE

Financials · 2025

LineValue
Revenue$15K
Net income-$6.5M
Operating income-$6.5M
Net margin-43832.5%
Operating margin-43737.5%
Revenue growth-57.5%
Cash$0
Total assets$7.8M
P/E (computed)Net income was not positive
P/S (computed)357.3×

Warning signs

Cash runway
0.0 months
$0 cash at September 30, 2026
Share count, 1 year
+62.1%
2025-11-12 to 2026-11-06 · +332.7% over 3 years
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-06
Cash and burn$0 cash; operating cash flow -$1.4M a quarter.Report 2026-09-30
Shares outstanding2,959,469 (2026-11-06); 1,826,051 a year earlier; 20,516,940 three years earlier. 3y figure adjusted for split (1-for-30 overall).Cover page 2026-11-06
Reverse splits, 3 years1; latest 1-for-30 on 2025-05-13Source 2025-05-13
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPrager Metis CPAs, LLC, Hackensack, New Jersey, United StatesPCAOB Form AP 2026-03-20
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$4K-$1.7M-$1.5M$0No debt tags$15K10-Q 2026-11-06
Q2 2026
2026-06-30
$5K-$1.5M-$1.3M$0No debt tags$14K10-Q 2026-08-07
Q1 2026
2026-03-31
$3K-$1.8M-$1.6M$0No debt tags$17K10-Q 2026-05-15
Q4 2025
2025-12-31
$4K-$1.5M-$1.4M$0No debt tags$15K10-K 2026-03-13
Q3 2025
2025-09-30
$3K-$1.7M-$1.4M$0No debt tags$16K10-Q 2026-11-06
Q2 2025
2025-06-30
$7K-$1.7M-$1.6M$0No debt tags$20K10-Q 2026-08-07
Q1 2025
2025-03-31
$940-$1.6M-$1.4M$0No debt tags$20K10-Q 2026-05-15
Q4 2024
2024-12-31
$5K-$1.5M-$1.4M$0No debt tags$35K10-K 2026-03-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B32025-09-23
Latest annual report
ANNUAL REPORT
10-K2026-03-13
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-11-06
Latest current report
FORM 8-K
8-K2026-09-18
Latest proxy
DEFINITIVE 14A ADDITIONAL MATERIALS
DEFA14A2026-09-08

Source: SEC EDGAR submissions feed, 296 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+14.5%
1 month+8.0%
3 months-6.0%
Year to date-30.3%
1 year-44.4%
From 52-week high-71.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Other listings for this company

TickerNamePrice
CDIOWCardio Diagnostics Holdings Inc Warrant$0.0078

Peers in Biotechnology: In Vitro & In Vivo Diagnostic Substances

TickerCompanyPriceDayMarket cap
BMRABiomerica Inc.$1.32-2.94%$6.1M
TRIBTrinity Biotech plc$5.38-11.89%$4.4M
VNRXVolitionRX Limited$0.1998-13.13%$7.2M
QCLSQ/C Technologies Inc.$0.3210+4.80%$2.6M
VRAXVirax Biolabs Group Limited$0.4480-26.87%$603K
IMDXInsight Molecular Diagnostics Inc.$1.86-13.08%$60.9M
ICCCImmuCell Corporation$11.42+6.23%$103.8M
TKNOAlpha Teknova Inc.$7.77-5.36%$488.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier